TGFB2 anticorps (AA 351-414)
Aperçu rapide pour TGFB2 anticorps (AA 351-414) (ABIN5675552)
Antigène
Voir toutes TGFB2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 351-414
-
Réactivité croisée
- Humain, Souris
-
Homologie
- Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human TGF beta 2
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- TGFB2 (Transforming Growth Factor, beta 2 (TGFB2))
-
Autre désignation
- TGF beta 2
-
Sujet
-
Synonyms: Transforming growth factor beta-2, TGFB2, TGF-beta-2, BSC-1 cell growth inhibitor, Cetermin, Glioblastoma-derived T-cell suppressor factor, G-TSF, Polyergin, TGFB2
Background: TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth.
-
ID gène
- 7042
-
UniProt
- P61812
-
Pathways
- Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Antigène
-